BRIEF-Sunshine Lake Pharma Enters Strategic Agreement With Shenzhen Xtalpi Technology
Reuters
Jan 26
BRIEF-Sunshine Lake Pharma Enters Strategic Agreement With Shenzhen Xtalpi Technology
Jan 26 (Reuters) - Sunshine Lake Pharma Co Ltd 6887.HK:
ENTERS STRATEGIC AGREEMENT WITH SHENZHEN XTALPI TECHNOLOGY
UNDER DEAL, PARTIES TO ESTABLISH JV TO BUILD AI-DRIVEN DRUG RESEARCH AND DEVELOPMENT PLATFORM, OTHERS
Further company coverage: 6887.HK
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.